Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mech Dev ; 95(1-2): 239-43, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10906470

ABSTRACT

The expression pattern of K(+) currents is the principal regulator of electrical activity during development of the nervous and muscular system. We report here a study showing the expression pattern of HERG K(+) currents-encoding (erg) genes in various nervous and muscular tissues at different stages of quail embryo development.


Subject(s)
Cation Transport Proteins , Gene Expression Regulation, Developmental , Potassium Channels, Voltage-Gated , Potassium Channels/genetics , Quail/embryology , Quail/genetics , Amino Acid Sequence , Animals , Embryo, Nonmammalian/physiology , Ether-A-Go-Go Potassium Channels , Molecular Sequence Data , Muscles/embryology , Nervous System/embryology , Sequence Alignment
2.
Leukemia ; 14(12): 2112-7, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11187900

ABSTRACT

Although dephosphorylation of tyrosine containing proteins is considered a necessary step in the induction of leukemia cell differentiation by hybrid polar compounds (HPC), the crucial actors in this step remain unknown. We present evidence that tyrosine phosphorylation of JAK1 and JAK2 is down-regulated in murine erythroleukemia cells (MELC) within the first 6 h of their exposure to the prototype of the HPC family, hexamethylenebisacetamide (HMBA), with full recovery at 14 h. Further evidence that the JAKs-centered signalling pathway is switched off early by HMBA was provided by the demonstration that STAT5, a downstream member of this pathway, turned out to be completely dephosphorylated at 6 h in HMBA-treated cells. This JAKs dephosphorylation did not occur in HMBA-resistant clones, suggesting that JAKs are possible targets of the dephosphorylative process required for leukemia cell commitment to differentiation. These results may have impact on leukemia therapy based on JAKs inhibitors.


Subject(s)
Acetamides/pharmacology , Cell Differentiation/drug effects , Leukemia, Erythroblastic, Acute/metabolism , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins , Animals , Janus Kinase 1 , Janus Kinase 2 , Leukemia, Erythroblastic, Acute/pathology , Mice , Phosphorylation , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...